Hansen Medical Inc. said Wednesday it signed a deal with St. Jude Medical to sell new products based on their technologies for treating heart rhythm disorders.
Terms of the deal were not disclosed.
Hansen said the deal will integrate St. Jude's EnSite Velocity Cardiac Mapping System with Hansen's Sensei X CoHesion 3-D visualization module. The latter will give physicians the ability to visualize, locate and robotically control catheters within the heart to diagnose heart rhythm disorders.
Shares of Hansen rose 4 cents to close at $1.48 while St. Jude shares fell 19 cents to close at $35.23.